NCT05117567

Brief Summary

This stepped-wedge cluster-randomized controlled trial with nested mixed methods study will assess the effectiveness, acceptability, feasibility and cost-effectiveness of a personal protection package to reduce malaria transmission among mobile and migrant populations (MMPs) and the general population in their residing villages in Lao People's Democratic Republic (PDR) and Cambodia.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
5,868

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2021

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 16, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

November 11, 2021

Completed
20 days until next milestone

Study Start

First participant enrolled

December 1, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
Last Updated

November 11, 2021

Status Verified

November 1, 2021

Enrollment Period

6 months

First QC Date

August 16, 2021

Last Update Submit

November 2, 2021

Conditions

Keywords

malariapreventionvectormigranteliminationvivaxfalciparumcommunity-deliveredintervention

Outcome Measures

Primary Outcomes (1)

  • Plasmodium spp. infection diagnosed by RDT

    Change in the number of Plasmodium spp. infections detected by RDT per week per village

    Assessed weekly, longitudinally over 12 months

Secondary Outcomes (10)

  • Symptomatic malaria diagnosed by RDT

    Assessed weekly, longitudinally over 12 months

  • Plasmodium spp. infection as determined by polymerase chain reaction (PCR) on RDT cassette samples

    Assessed weekly, longitudinally over 12 months

  • Plasmodium spp. infection as determined by polymerase chain reaction (PCR) on dried blood spot samples

    Assessed weekly, longitudinally over 12 months

  • Plasmodium spp. infections with drug resistance mutations

    Assessed weekly, longitudinally over 12 months

  • Prevalence of antibodies to Plasmodium spp.

    Assessed weekly, longitudinally over 12 months

  • +5 more secondary outcomes

Study Arms (2)

Personal protection package

EXPERIMENTAL

A personal protection package that includes Long-lasting insecticidal hammock net (LLIHN), insect repellent (Icaridin), and mobile and migrant population-tailored behavioural change communication (BCC) package

Combination Product: Personal protection package

Control

NO INTERVENTION

No personal protection package

Interventions

Personal protection packageCOMBINATION_PRODUCT

A personal protection package that includes Long-lasting insecticidal hammock net (LLIHN), insect repellent (Icaridin), and MMP-tailored behavioural change communication (BCC) package

Personal protection package

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Mobile and migrant individuals aged 18 years and over in selected villages including:
  • Traditional slash-and-burn and paddy field farming communities visiting their forest farms (commonly ethnic minority groups)
  • Seasonal agricultural laborers
  • Forest workers in the informal sector (hunters, small-scale gem/gold miners, people gathering forest products (precious timber, construction timber, rattan/bamboo)
  • Transient or mobile camp residents associated with commercial projects (road/pipeline construction, large-scale logging, deep seaport projects, etc.)
  • Formal and informal cross-border migrant workers
  • For qualitative research component, local health stakeholders meeting the following criteria will be eligible:
  • Aged 18 years and over
  • The local health stakeholders such as health centre staff, Operational District Malaria Supervisor (ODMS), and Provincial Malaria Supervisor (PMS), and basic health staff such as malaria unit staff in health centres, midwives, health assistants, district health officers and district focal person from CMPE and CNM
  • Health staff members from HPA and Lao malaria community service organisations

You may not qualify if:

  • A village will be excluded from the study if:
  • The village has an VHV/VMW program operated by any organizations other than CMPE, CNM, HPA, malaria CSOs in Lao PDR The village has no malaria cases or API less than 1 in any of the past three years (2018 - 2020) The village has no MMPs The village has no VHV/VMW The village has a government health facility for provision of malaria services

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Gabaldon Figueira JC, Wagah MG, Adipo LB, Wanjiku C, Maia MF. Topical repellents for malaria prevention. Cochrane Database Syst Rev. 2023 Aug 21;8(8):CD015422. doi: 10.1002/14651858.CD015422.pub2.

  • Htike W, Oo WH, Lynn T, Sovanda L, Agius PA, Oo MC, Galau NH, Thu KM, Zaw AK, Htwe EP, Cutts JC, Kearney EA, Scott N, O'Flaherty K, Wang B, Khamlome B, Vilay P, Siv S, Fowkes FJI. Reducing malaria transmission in forest-going mobile and migrant populations in Lao PDR and Cambodia: protocol for stepped-wedge cluster-randomised controlled trial. BMC Infect Dis. 2022 Sep 24;22(1):747. doi: 10.1186/s12879-022-07724-5.

MeSH Terms

Conditions

Malaria

Condition Hierarchy (Ancestors)

Protozoan InfectionsParasitic DiseasesInfectionsMosquito-Borne DiseasesVector Borne Diseases

Central Study Contacts

Freya JI Fowkes, DPhil

CONTACT

Julia C Cutts, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: Stepped-wedge cluster-randomized controlled trial (one-way crossover) with nested mixed methods study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 16, 2021

First Posted

November 11, 2021

Study Start

December 1, 2021

Primary Completion

June 1, 2022

Study Completion

June 1, 2022

Last Updated

November 11, 2021

Record last verified: 2021-11